1. Academic Validation
  2. Identification of a novel aspartic protease (Asp 2) as beta-secretase

Identification of a novel aspartic protease (Asp 2) as beta-secretase

  • Mol Cell Neurosci. 1999 Dec;14(6):419-27. doi: 10.1006/mcne.1999.0811.
I Hussain 1 D Powell D R Howlett D G Tew T D Meek C Chapman I S Gloger K E Murphy C D Southan D M Ryan T S Smith D L Simmons F S Walsh C Dingwall G Christie
Affiliations

Affiliation

  • 1 Department of Neurosciences, SmithKline Beecham Pharmaceuticals, Harlow, Essex, United Kingdom.
Abstract

The Alzheimer's disease beta-amyloid peptide (Abeta) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of beta- and then gamma-secretases. Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of Beta-secretase. Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-associated C-terminal Beta-secretase APP fragment. Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the production of the fragments characteristic of cleavage at the Beta-secretase site. The Enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Abeta. Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.

Figures